2311 related articles for article (PubMed ID: 23482247)
1. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
2. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
Softic S; Cohen DE; Kahn CR
Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
[TBL] [Abstract][Full Text] [Related]
3. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
[TBL] [Abstract][Full Text] [Related]
4. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
Kohli R; Kirby M; Xanthakos SA; Softic S; Feldstein AE; Saxena V; Tang PH; Miles L; Miles MV; Balistreri WF; Woods SC; Seeley RJ
Hepatology; 2010 Sep; 52(3):934-44. PubMed ID: 20607689
[TBL] [Abstract][Full Text] [Related]
5. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.
Tetri LH; Basaranoglu M; Brunt EM; Yerian LM; Neuschwander-Tetri BA
Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G987-95. PubMed ID: 18772365
[TBL] [Abstract][Full Text] [Related]
6. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.
Ter Horst KW; Serlie MJ
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878197
[TBL] [Abstract][Full Text] [Related]
7. Dietary carbohydrates and fatty liver disease: de novo lipogenesis.
Chiu S; Mulligan K; Schwarz JM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):277-282. PubMed ID: 29697539
[TBL] [Abstract][Full Text] [Related]
8. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
9. Does fructose consumption contribute to non-alcoholic fatty liver disease?
Tappy L; Lê KA
Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):554-60. PubMed ID: 22795319
[TBL] [Abstract][Full Text] [Related]
10. Hepatic adverse effects of fructose consumption independent of overweight/obesity.
Schultz A; Neil D; Aguila MB; Mandarim-de-Lacerda CA
Int J Mol Sci; 2013 Nov; 14(11):21873-86. PubMed ID: 24196354
[TBL] [Abstract][Full Text] [Related]
11. Dietary fructose in nonalcoholic fatty liver disease.
Vos MB; Lavine JE
Hepatology; 2013 Jun; 57(6):2525-31. PubMed ID: 23390127
[TBL] [Abstract][Full Text] [Related]
12. Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism.
Jegatheesan P; De Bandt JP
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273805
[TBL] [Abstract][Full Text] [Related]
13. Mini review on fructose metabolism.
Akram M; Hamid A
Obes Res Clin Pract; 2013; 7(2):e89-e94. PubMed ID: 24331770
[TBL] [Abstract][Full Text] [Related]
14. Soft drinks consumption and nonalcoholic fatty liver disease.
Nseir W; Nassar F; Assy N
World J Gastroenterol; 2010 Jun; 16(21):2579-88. PubMed ID: 20518077
[TBL] [Abstract][Full Text] [Related]
15. Fructose consumption as a risk factor for non-alcoholic fatty liver disease.
Ouyang X; Cirillo P; Sautin Y; McCall S; Bruchette JL; Diehl AM; Johnson RJ; Abdelmalek MF
J Hepatol; 2008 Jun; 48(6):993-9. PubMed ID: 18395287
[TBL] [Abstract][Full Text] [Related]
16. Fructose and hepatic insulin resistance.
Softic S; Stanhope KL; Boucher J; Divanovic S; Lanaspa MA; Johnson RJ; Kahn CR
Crit Rev Clin Lab Sci; 2020 Aug; 57(5):308-322. PubMed ID: 31935149
[TBL] [Abstract][Full Text] [Related]
17. Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
Gugliucci A
Med Hypotheses; 2016 Aug; 93():87-92. PubMed ID: 27372863
[TBL] [Abstract][Full Text] [Related]
18. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.
Moore JB; Gunn PJ; Fielding BA
Nutrients; 2014 Dec; 6(12):5679-703. PubMed ID: 25514388
[TBL] [Abstract][Full Text] [Related]
19. Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.
Dowman JK; Hopkins LJ; Reynolds GM; Nikolaou N; Armstrong MJ; Shaw JC; Houlihan DD; Lalor PF; Tomlinson JW; Hübscher SG; Newsome PN
Am J Pathol; 2014 May; 184(5):1550-61. PubMed ID: 24650559
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
